Literature DB >> 23066784

Is CD34 truly a negative marker for mesenchymal stromal cells?

Ching-Shwun Lin1, Hongxiu Ning, Guiting Lin, Tom F Lue.   

Abstract

The prevailing school of thought is that mesenchymal stromal cells (MSC) do not express CD34, and this sets MSC apart from hematopoietic stem cells (HSC), which do express CD34. However, the evidence for MSC being CD34(-) is largely based on cultured MSC, not tissue-resident MSC, and the existence of CD34(-) HSC is in fact well documented. Furthermore, the Stro-1 antibody, which has been used extensively for the identification/isolation of MSC, was generated by using CD34(+) bone marrow cells as immunogen. Thus, neither MSC being CD34(-) nor HSC being CD34(+) is entirely correct. In particular, two studies that analyzed CD34 expression in uncultured human bone marrow nucleated cells found that MSC (BMSC) existed in the CD34(+) fraction. Several studies have also found that freshly isolated adipose-derived MSC (ADSC) express CD34. In addition, all of these ADSC studies and several other MSC studies have observed a disappearance of CD34 expression when the cells are propagated in culture. Thus the available evidence points to CD34 being expressed in tissue-resident MSC, and its negative finding being a consequence of cell culturing.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23066784      PMCID: PMC3846603          DOI: 10.3109/14653249.2012.729817

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  54 in total

1.  Characterization of endothelial-like cells derived from human mesenchymal stem cells.

Authors:  J W Liu; S Dunoyer-Geindre; V Serre-Beinier; G Mai; J-F Lambert; R J Fish; G Pernod; L Buehler; H Bounameaux; E K O Kruithof
Journal:  J Thromb Haemost       Date:  2007-01-09       Impact factor: 5.824

2.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

Authors:  M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

Review 3.  Concise review: multipotent mesenchymal stromal cells in blood.

Authors:  Qiling He; Chao Wan; Gang Li
Journal:  Stem Cells       Date:  2006-09-14       Impact factor: 6.277

4.  Influence of host irradiation on long-term engraftment by CD34-deficient hematopoietic stem cells.

Authors:  Julie S Nielsen; Kelly M McNagny
Journal:  Blood       Date:  2007-08-01       Impact factor: 22.113

Review 5.  Adipose-derived stem cells for regenerative medicine.

Authors:  Jeffrey M Gimble; Adam J Katz; Bruce A Bunnell
Journal:  Circ Res       Date:  2007-05-11       Impact factor: 17.367

6.  Characterization and histological localization of multipotent mesenchymal stromal cells in the human postnatal thymus.

Authors:  Moubarak Mouiseddine; Noëlle Mathieu; Johanna Stefani; Christelle Demarquay; Jean-Marc Bertho
Journal:  Stem Cells Dev       Date:  2008-12       Impact factor: 3.272

7.  Defining stem and progenitor cells within adipose tissue.

Authors:  Guiting Lin; Maurice Garcia; Hongxiu Ning; Lia Banie; Ying-Lu Guo; Tom F Lue; Ching-Shwun Lin
Journal:  Stem Cells Dev       Date:  2008-12       Impact factor: 3.272

8.  BM cells giving rise to MSC in culture have a heterogeneous CD34 and CD45 phenotype.

Authors:  S Kaiser; B Hackanson; M Follo; A Mehlhorn; K Geiger; G Ihorst; U Kapp
Journal:  Cytotherapy       Date:  2007       Impact factor: 5.414

9.  CD34 expression on murine marrow-derived mesenchymal stromal cells: impact on neovascularization.

Authors:  Ian Copland; Kapil Sharma; Laurence Lejeune; Nicoletta Eliopoulos; Duncan Stewart; Peter Liu; Kevin Lachapelle; Jacques Galipeau
Journal:  Exp Hematol       Date:  2007-11-26       Impact factor: 3.084

10.  Rapid expansion of human adipose-derived stromal cells preserving multipotency.

Authors:  H Suga; T Shigeura; D Matsumoto; K Inoue; H Kato; N Aoi; S Murase; K Sato; K Gonda; I Koshima; K Yoshimura
Journal:  Cytotherapy       Date:  2007       Impact factor: 5.414

View more
  69 in total

1.  Phenotypic Characterization of Adherent Cells Population CD34+ CD90+ CD105+ Derived from Wharton's Jelly.

Authors:  Irena Walecka; Paulina Gil-Kulik; Arkadiusz Krzyżanowski; Marcin Czop; Dariusz Galkowski; Jolanta Karwat; Piotr Chomik; Małgorzata Świstowska; Anna Kwaśniewska; Anna Bogucka-Kocka; Janusz Kocki
Journal:  Med Sci Monit       Date:  2017-04-19

Review 2.  Mesenchymal stem cells as a potent cell source for articular cartilage regeneration.

Authors:  Mohamadreza Baghaban Eslaminejad; Elham Malakooty Poor
Journal:  World J Stem Cells       Date:  2014-07-26       Impact factor: 5.326

3.  BM-MSCs and Bio-Oss complexes enhanced new bone formation during maxillary sinus floor augmentation by promoting differentiation of BM-MSCs.

Authors:  Qian Zhou; Bo-Han Yu; Wei-Cai Liu; Zuo-Lin Wang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-06-01       Impact factor: 2.416

4.  Isolation, Culture, and Differentiation of Bone Marrow Stromal Cells and Osteoclast Progenitors from Mice.

Authors:  David E Maridas; Elizabeth Rendina-Ruedy; Phuong T Le; Clifford J Rosen
Journal:  J Vis Exp       Date:  2018-01-06       Impact factor: 1.355

5.  An expanded population of CD34+ cells from frozen banked umbilical cord blood demonstrate tissue repair mechanisms of mesenchymal stromal cells and circulating angiogenic cells in an ischemic hind limb model.

Authors:  Jennifer Whiteley; Ryszard Bielecki; Mira Li; Shawn Chua; Michael R Ward; Nobuko Yamanaka; Duncan J Stewart; Robert F Casper; Ian M Rogers
Journal:  Stem Cell Rev Rep       Date:  2014-06       Impact factor: 5.739

6.  Effects of autologous stromal cells and cytokines on differentiation of equine bone marrow-derived progenitor cells.

Authors:  Ute E Schwab; Rebecca L Tallmadge; Mary Beth Matychak; M Julia B Felippe
Journal:  Am J Vet Res       Date:  2017-10       Impact factor: 1.156

7.  Effect of intracameral human cord blood-derived stem cells on lasered rabbit trabecular meshwork.

Authors:  Ramanjit Sihota; Seema Sen; Sujata Mohanty; Mohammad Ahmad; Alok Ravi; Viney Gupta; Neerja Bhatla
Journal:  Int Ophthalmol       Date:  2019-05-28       Impact factor: 2.031

Review 8.  Commonly used mesenchymal stem cell markers and tracking labels: Limitations and challenges.

Authors:  Ching-Shwun Lin; Zhong-Cheng Xin; Jican Dai; Tom F Lue
Journal:  Histol Histopathol       Date:  2013-04-16       Impact factor: 2.303

9.  Characterization and Classification of Mesenchymal Stem Cells in Several Species Using Surface Markers for Cell Therapy Purposes.

Authors:  Hori Ghaneialvar; Leila Soltani; Hamid Reza Rahmani; Abbas Sahebghadam Lotfi; Masoud Soleimani
Journal:  Indian J Clin Biochem       Date:  2017-02-10

10.  Mesenchymal Stem Cell-Like Properties of Orbital Fibroblasts in Graves' Orbitopathy.

Authors:  Katarzyna Kozdon; Caroline Fitchett; Geoffrey E Rose; Daniel G Ezra; Maryse Bailly
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.